$NASDAQ:MRUS

FDA Grants Extension for Merus’ Cancer Drug Zeno Review, Merus N.V. Prepares for Potential Breakthrough Treatment
Gallery

FDA Grants Extension for Merus’ Cancer Drug Zeno Review, Merus N.V. Prepares for Potential Breakthrough Treatment

🌧️Trending News Merus ($NASDAQ:MRUS) N.V. is a biotechnology company that specializes in developing innovative cancer treatments. The company's main focus [...]

By GoodWhale|November 9, 2024|Categories: Biotechnology|Tags: $NASDAQ:MRUS, Biotechnology, NASDAQ|0 Comments

Merus N.v Intrinsic Value Calculation – UBS Group initiates coverage on Merus N.V with a “buy” rating and $72 price target
Gallery

Merus N.v Intrinsic Value Calculation – UBS Group initiates coverage on Merus N.V with a “buy” rating and $72 price target

🌥️Trending News Merus ($NASDAQ:MRUS) N.V is a biotechnology company based in the Netherlands that focuses on the development of innovative [...]

By GoodWhale|October 29, 2024|Categories: Biotechnology, Intrinsic Value, Market Price|Tags: $NASDAQ:MRUS, Biotechnology, NASDAQ|0 Comments

Merus N.V. Proves Resilient in Market, Finishes Slightly Lower at 51.35
Gallery

Merus N.V. Proves Resilient in Market, Finishes Slightly Lower at 51.35

🌧️Trending News Merus ($NASDAQ:MRUS) N.V., a biotechnology company based in the Netherlands, has recently made headlines with its resilient performance [...]

By GoodWhale|October 19, 2024|Categories: Biotechnology|Tags: $NASDAQ:MRUS, Biotechnology, NASDAQ|0 Comments

TD Asset Management Inc reduces Merus N.V stake by 15.6% in 2nd quarter
Gallery

TD Asset Management Inc reduces Merus N.V stake by 15.6% in 2nd quarter

☀️Trending News MERUS N.V ($NASDAQ:MRUS) is a Dutch biotechnology company that specializes in developing innovative antibody-based cancer therapies. The company's [...]

By GoodWhale|September 13, 2024|Categories: Biotechnology|Tags: $NASDAQ:MRUS, Biotechnology, NASDAQ|0 Comments

Merus N.V Receives Mixed Ratings from Investment Analysts – Downgraded to “Sell” by StockNews.com but Price Target Raised
Gallery

Merus N.V Receives Mixed Ratings from Investment Analysts – Downgraded to “Sell” by StockNews.com but Price Target Raised

🌥️Trending News MERUS N.V ($NASDAQ:MRUS) is a biotechnology company that focuses on developing innovative therapies for cancer treatment. The company's [...]

By GoodWhale|March 26, 2024|Categories: Biotechnology, Market Price|Tags: $NASDAQ:MRUS, Biotechnology, NASDAQ|0 Comments

MERUS N.V Shares Plummet Following Release of Updated Data for Lung Cancer Therapy
Gallery

MERUS N.V Shares Plummet Following Release of Updated Data for Lung Cancer Therapy

🌧️Trending News Shares in MERUS N.V ($NASDAQ:MRUS), a biotechnology company focused on the development of innovative cancer immunotherapies, have taken [...]

By GoodWhale|December 6, 2023|Categories: Biotechnology|Tags: $NASDAQ:MRUS, Biotechnology, NASDAQ|0 Comments

Analysts Unanimously Recommend ‘Buy’ for Merus N.V. Stock
Gallery

Analysts Unanimously Recommend ‘Buy’ for Merus N.V. Stock

☀️Trending News Analysts have unanimously given Merus ($NASDAQ:MRUS) N.V stock a 'Buy' rating, according to MarketBeat. This recommendation is based [...]

By GoodWhale|July 26, 2023|Categories: Biotechnology|Tags: $NASDAQ:MRUS, Biotechnology, NASDAQ|0 Comments

Merus N.v Intrinsic Stock Value – Insider Activity at Merus N.V. Pushes Potential Price Increase – VP Controller, PAO Shuman Harry Unloads Shares for $12351.0
Gallery

Merus N.v Intrinsic Stock Value – Insider Activity at Merus N.V. Pushes Potential Price Increase – VP Controller, PAO Shuman Harry Unloads Shares for $12351.0

☀️Trending News Merus ($NASDAQ:MRUS) N.V. is a biotechnology company focused on next-generation immuno-oncology therapies. Recently, the VP Controller and PAO [...]